Drugs / GSK3536852A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03527173 | Aug 2018 → May 2019 | shigellosis | GlaxoSmithKline | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK3536852A | “GSK3536852A vaccine” NCT03527173 ↗ |
| Modality | Vaccine | “GSK3536852A vaccine” NCT03527173 ↗ |